
Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulationsBusiness Overview: BPL is a Gujarat-based WHO GMP & an ISO 10002: 2014, 9001: 2015 certified pharmaceutical company. It manufactures over 800 products spread over 20+ different categories including General Products, β-Lactum/ Cephalosporin Products, Formulations in the form...
Bharat Parenterals Limited has announced its 33rd Annual General Meeting (AGM), scheduled for Saturday, September 19, 2026, at 11:00 a.m. IST. The company will conduct this important shareholder engagement entirely through Video Conferencing or Other Audio-Visual Means. This virtual format ensures broader participation for investors. The AGM offers a crucial...
Bharat Parenterals Limited has sent letters to shareholders without registered email addresses, providing a web-link to the Annual Report for Financial Year 2025-26 and the Notice for the 33rd Annual General Meeting (AGM). The AGM is scheduled for Saturday, September 19, 2026, at 11:00 A.M. via Video Conferencing/Other Audio-Visual Means....
Bharat Parenterals Limited has fixed Saturday September 12, 2026, as the Record Date for determining shareholder entitlement to the dividend for the financial year 2025-26. Only shareholders holding shares as beneficial owners by the close of business on this date will be eligible for the dividend. This payment is contingent...